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Abstract CFTR-NBF-2 expressed and purified in fusion with 
the maltose-binding protein was shown to catalyse the reaction 
ATP^ADP+Pi by three different assays, monitoring ATP 
turnover, formation of ADP and release of P; (Km 86 jiM, rate 
constant 0.37 min 1). The reaction product ADP inhibits this 
ATPase activity. In a similar manner the hydrolysis of GTP to 
GDP and Pi was demonstrated (Km 40 uM, rate constant 0.29 
min J). In the presence of AMP the ATPase reaction was 
superseded by the formation of two ADP from ATP and AMP. 
As typical for adenylate kinases a distinct AMP-binding site 
could be verified for CFTR-NBF-2 by the inability of TNP-
ATP and AMP to compete for binding. All three enzymatic 
activities were inhibited by the symmetric double-substrate-
mimicking inhibitor Ap5A. As NBF-2 plays a central role in 
CFTR channel opening and closing the results reported here are 
fundamental in understanding mechanisms of CFTR channel 
activity regulation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The most common fatal autosomal recessive genetic disease 
affecting Caucasian populations, cystic fibrosis [1], is caused 
by mutations of the cystic fibrosis transmembrane conduc-
tance regulator (CFTR). This protein has been demonstrated 
to be a membrane chloride channel [2,3]. It has been predicted 
to be composed of two transmembrane domains of six trans-
membrane spanning segments each, that are both followed by 
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a nucleotide-binding fold, and a fifth domain — a unique 
regulatory (R) domain — linking both halves of the protein 
[4]. Both CFTR-NBFs were identified by sequence homolo-
gies to adenylate kinase and to other NBFs of the ATP-bind-
ing cassette family [5] including the occurrence of Walker A 
and B consensus sequences [6] present in the nucleotide-bind-
ing pockets of many proteins. In addition, a similarity in the 
amino acid sequences of CFTR-NBFs and the sequences of 
heterotrimeric G-proteins is evident [7]. CFTR channel open-
ing requires both phosphorylation by cAMP-dependent pro-
tein kinases [8] and the presence of cytosolic hydrolyzable 
MgATP [9,10]. Since single mutations in both CFTR-NBFs 
can impair the rate of phosphorylated channels to open, the 
activating effect of MgATP seems to be mediated by both 
NBFs [11-14]. Cytosolic ADP [11] as well as AMP [10] 
have been shown to act as inhibitors of channel activity and 
evidence has been presented from electrophysiological data 
that inhibition by ADP is a function of NBF-2 [11]. Further-
more, it could be demonstrated that the closure of CFTR 
channels previously opened by ATP is coupled to ATP hy-
drolysis [15] providing the energy for the transition from a 
longer-lived, lower conductance open state to a shorter-lived, 
higher conductance open state, an event that is subsequently 
followed by transition to the closed state [16]. Indirect evi-
dence that ATP hydrolysis closing the channel takes place 
at NBF-2 has been gained from the observation that single 
amino acid substitutions of highly conserved residues within 
the Walker motifs of NBF-2 produce channels with prolonged 
bursts of activity [13,14] by inhibiting the transition to the 
shorter-lived second open state [16]. In contrast to NBF-1, 
that appears to be only involved in channel opening, NBF-2 
seems to regulate both channel opening and closing 
[11,13,14,16] and a CFTR construct with deleted NBF-2 has 
been shown to be not functional despite being properly local-
ized in the plasma membrane [17]. In order to achieve a better 
understanding of the individual regulatory events that are 
required for CFTR channel opening and closing and of the 
effects of CF causing mutations the enzymatic properties of 
isolated CFTR domains have to be studied and related to 
known electrophysiological data. We recently demonstrated 
that a recombinant CFTR-NBF-2 polypeptide is able to 
bind all three adenine nucleotides with high affinity [18] and 
that there exists a common binding site for ATP and GTP 
[19]. Up to now — in contrast to a recombinant model of 
CFTR-NBF-1 exhibiting not only ATP-binding [20] but 
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also ATPase activity [21] — no experimental data have 
been published directly demonstrating enzymatic activity of 
NBF-2. 
In the present study we give the first direct experimental 
evidence that a recombinant NBF-2 polypeptide possesses a 
unique combination of enzymatic activities. We demonstrate 
that this domain is not only an active ATPase and GTPase 
but also an adenylate kinase with an additional AMP-binding 
site different to the ATP/GTP-binding site. 
2. Materials and methods 
2.1. Overexpression and purification of MBP-NBF-2 fusion proteins 
The CFTR cDNA sequence from base 3754 to base 4331 [4] coding 
for the CFTR protein sequence from Gly-1208 to Leu-1399 (number-
ing according to Ref. [4]), that encloses the whole predicted NBF-2, 
was amplified by PCR from the expression vector pGEX-NBF-2 [18] 
using the oligonucleotides 5'-CTCGGGAATTCGGCCAAATGACT-
GTCAAAGATC-3' and 5'-GAGCCTGCAGTTATCAGAGAATT-
ACTGTGCAATCAGC-3' as primers. PCR amplified products were 
digested with EcoRl and Pstl restriction enzymes and finally ligated 
into the EcoRI/Pstl-cut pMAL«»-c2 expression vector [22,23] (New 
England Biolabs®) in frame with the coding sequence for MBP ac-
cording to standard procedures [24]. Plasmids of transformants show-
ing positive inducible expression of a fusion protein of the appropriate 
size were isolated and both strands of the inserted DNA were com-
pletely sequenced using an Applied Biosystems automated sequencer 
to exclude amino acid substitutions in the CFTR-NBF-2 part of the 
expressed fusion protein due to fidelity constraints of the PCR reac-
tion. 
Overexpression of MBP-NBF-2 and preparing soluble E. coli pro-
teins were performed as described before [18]. The latter were loaded 
on a column containing amylose resin previously equilibrated with the 
column buffer (20 mM Tris-HCl, pH 7.4, 200 mM NaCl, 1 mM 
EDTA). After washing with 20 column volumes of column buffer 
the fusion protein was eluted with 10 mM maltose dissolved in the 
column buffer. In a final step the isolated fusion protein was exten-
sively dialyzed over 20 h against a 1000-fold excess of 50 mM Tris-
HCl, pH 7.5, that was exchanged 3 times. The amount of fusion 
protein was quantified spectrophotometrically (A^) using a molar 
absorption coefficient of 64720 M _ 1 cm - 1 . 
2.2. HPLC, amino acid sequence analysis and mass spectroscopy 
HPLC, Lys-C digestion and amino acid sequencing were done as 
described [18] with an amount of 400 pmol of purified protein. Masses 
were determined with a tandem quadrupole instrument API III 
equipped with an atmospheric pressure ionization source (Sciex, 
Thornhill, Ontario, Canada). The instrument mlz scale was calibrated 
with the ammonium adduct ions of polypropylene glycol. The average 
molecular mass values of the Lys-C digestion products were calculated 
Fig. 1. Analysis by SDS-PAGE of overexpressed and purified 
MBP-NBF-2. Lane 1, molecular size markers are myosin H-chain 
(200 kDa), phosphorylase B (97.4 kDa), bovine serum albumin 
(68.0 kDa), ovalbumin (43.0 kDa), a-chymotrypsinogen (25.7 kDa), 
(3-lactoglobulin (18.4 kDa), and lysozyme (14.3 kDa). Lane 2, 
whole-cell lysate of uninduced E. coli (3 X108 cells). Lane 3, whole-
cell lysate of E. coli (3X108 cells) after IPTG induction. Lane 4, 
soluble proteins of the induced E. coli of lane 3, which were subse-
quently further purified by affinity chromatography. Lane 5, MBP-
NBF-2 (11.5 ug) purified by amylose affinity chromatography (Coo-
massie-stained 12.5% SDS-PAA-gel). Lane 6, 1.5 ug of the purified 
MBP-NBF-2 run on a silver-stained 12.5% PAA-gel. 
from the mlz peaks in the charge distribution profiles of the multiply 
charged ions [25]. 
2.3. Assays for detecting and measuring enzymatic activity 
The consumption of ATP in the presence of MBP-NBF-2 was 
detected with the ATP Bioluminescence Assay Kit CLS II (Boeh-
ringer-Mannheim) at 25°C. Luciferase reagent (100 u.1) from the kit 
(containing D-luciferin and luciferase from Photinus pyralis) were 
mixed with 100 ul of a 2X10 - 6 M MgATP solution. After 5 min 
the indicated amount of MBP-NBF-2 or the control reagents, respec-
tively, was added and stirred for 30 s. The flow of photons directly 
proportional to the ATP concentration in the assay was monitored 
continuously at 562 nm via the emission pathway of a SPEX Fluo-
roMax fluorometer (slit width 7.0 mm). 
The assays to detect nascent ADP and GDP, respectively, were 
Table 1 
Characterization of the Lys-C digestion products of the recombinant CFTR-NBF-2 by mass spectroscopy and amino acid sequencing 
Fragment Amino acid position Theoretical mass 
(MH+) 
Determined mass 
(MH+) 
N-terminal sequencing 
1 (linker) 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
- 2 8 - 6 
7- 11 
12- 43 
44- 77 
78- 85 
86- 95 
96-110 
111-127 
128-144 
145-156 
157-158 
159-182 
183-192 
3697.85 (av) 
547.31 
3280.67 (av) 
3920.46 (av) 
859.5 
1201.67 
1950.89 
1843.99 
1795.92 
1348.74 
218.15 
2806.33 (av) 
1080.54 
3697.8 (av) 
n.d. 
3279.6 (av) 
n.d. 
859.6 
1201.6 
1951.4 
n.d. 
1796.2 
1348.0 
n.d. 
2805.4 (av) 
1080.6 
- 2 8 to ■ 
n.d. 
n.d. 
44-
78-
86-
n.d. 
111-
n.d. 
145-
n.d. 
n.d. 
183-
46 
80 
92 
-114 
-150 
-187 
-22 
Amino acid positions of the 192 CFTR amino acids containing NBF-2 were numbered with positive numbers (positions 1-192 correspond to amino 
acids 1208-1399 of CFTR [4]). Negative numbers refer to the MBP fusion partner with —1 being the C-terminus of the linker motif. Masses above 
2000 are given as average (av) and not as monoisotopic masses. N-terminal sequencing was performed where indicated (n.d. = not determined). 
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Fig. 2. ATPase activity of MBP-NBF-2 monitored by following the 
disappearance of ATP in the luciferin-luciferase chemiluminescence 
assay. No decrease in the chemiluminescence signal measured as 
counts per second (cps) at 562 nm was recognized after adding 
MBP or Tris-buffer. All experiments were repeated at least twice 
and similar results were obtained. 
performed as described [18,19] with the following alterations of assay 
buffer composition; the indicated amount of ATP or GTP, respec-
tively, and the protein (2-A uM) were incubated together with 3 mM 
phosphoewo/pyruvate, 0.27 mM NADH, 6.5 mM magnesium acetate, 
34 mM KC1, 4.17 ng (1.9 U) lactate dehydrogenase and 12.5 ug (1-9 
U) pyruvate kinase (Boehringer-Mannheim) in 50 mM Tris-HCl, pH 
7.5, in a total volume of 360 |xl at 25°C. The ADP detection assay 
containing 1 mM ATP and no ATPase was also used to determine 
AMP concentrations. For this purpose 5 u.g (1.8 U) adenylate kinase 
from hog muscle (Boehringer-Mannheim) was added. The addition of 
AMP resulted in formation of two ADP per molecule AMP leading to 
a decrease in A3i0 proportional to the concentration of AMP. The 
same amount of adenylate kinase was added if traces of AMP present 
in the enzyme and ATP preparation had to be consumed in order to 
assume CAMP to be zero. 
The release of inorganic phosphate was measured according a 
method described by Webb [26] using the EnzChek45' Phosphate As-
say Kit (Molecular Probes). The indicated amount of the protein of 
interest was incubated together with the specified nucleotides at 25°C 
in a 360-ul system of 20 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 0.1 mM 
sodium azide, 0.2 mM MESG substrate and 1 U of purine nucleoside 
phosphorylase. A^o/Ar was monitored, which is a linear function of 
the rate of phosphate release, since in the presence of Pj purine nu-
cleoside phosphorylase catalyses phosphorolysis of MESG to ribose-
1-phosphate and 2-amino-6-mercapto-7-methylpurine resulting in an 
increase of absorbance at 360 nm (change in extinction coefficient at 
pH 7.6: 11000 M ^ X c m - 1 ) [26]. Without protein and nucleotides 
this assay was used to determine Pj concentrations of sample aliquots 
as described by Webb [26]. 
2.4. Nucleotide-binding studies 
Fluorescence measurements recording the binding of TNP-ATP to 
MBP-NBF-2 and competition of this binding by unlabelled nucleo-
tides, corrections for unspecific binding of TNP-ATP and for inner 
filter effect, and fitting of monophasic binding curves to the corrected 
fluorescence data were done according to the methods described in 
[18,19] with a protein concentration of 6.75 uM. 
3. Results and discussion 
The second nucleotide-binding fold (NBF-2) of C F T R was 
expressed in fusion with the maltose-binding protein (MBP) in 
E. coli as described in Section 2. In contrast to our earlier 
studies [18,19] the initial washing step of the purification pro-
tocol with PBS containing 1% Triton X-100 was omitted since 
we could show that this extensive exposure to Tri ton X-100 
was the main reason for our previous failure to demonstrate 
ATPase and GTPase activity [18,19]. As shown in Fig. 1, the 
expression of a 64.2 k D a protein (42.71 k D a for M B P +21.49 
k D a for NBF-2) under the control of the tac p romotor after 
induction with IPTG is strikingly evident. Most of the over-
expressed protein was found in the soluble protein fraction. 
The effectiveness of the employed purification procedure re-
sulting in 5-6 mg of purified NBF-2 fusion protein per liter of 
E. coli culture is illustrated in Fig. 1. Silver staining revealed 
no other proteins larger than the cutoff molecular mass of the 
gel. H P L C and N-terminal sequence analysis detected only a 
single N-terminal sequence in agreement with the seven N -
terminal residues of the M B P fusion partner. In addition, 
the masses of nine internal protein fragments expected to cov-
er 70% of the NBF-2 sequence were determined and found to 
be in excellent agreement with their theoretical masses. Fo r 
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Fig. 3. Enzymatic activity of MBP-NBF-2 monitored by following the formation of ADP in a 'coupled' (PK/LDH) ATP-regenerating enzy-
matic assay. Left panel: no AMP was added. Right panel: the effect of increasing amounts of AMP at a constant concentration of 1 mM 
ATP on ADP formation is illustrated. This experiment was repeated 3 times with similar results. 
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time (min) 
Fig. 4. ATPase activity of MBP-NBF-2 and of (Na+,K+)ATPase at 1 mM ATP monitored by following the release of P;, and the influence of 
AMP and ADP on ATP hydrolysis by MBP-NBF-2. All experiments were repeated, and similar results were obtained. 
seven of these Lys-C digestion products N-terminal sequenc-
ing was performed and no aberration to the expected NBF-2 
sequence was detected (Table 1). Based on these experiments 
we estimate the protein employed in the studies reported here 
to be more than 95% pure. 
In order to determine directly whether MBP-NBF-2 has the 
capacity to catalyse the hydrolysis of ATP, three completely 
different assays were used: one to detect the disappearance of 
the substrate ATP, one to detect nascent ADP and the third 
to detect nascent P;. Fig. 2 illustrates the first assay based on 
the disappearance of ATP, which includes the luciferin/lucifer-
ase reaction to monitor ATP levels. Upon addition of ATP to 
the luciferin/luciferase system, a chemiluminescence response 
is detected that levels off to a near zero decay rate and re-
mains stable over more than 30 min. In contrast to a control 
experiment with the isolated fusion partner MBP, addition of 
the NBF-2 fusion protein causes a rapid decrease of the chem-
iluminescence signal indicating the disappearance of ATP. In 
order to prove the turnover of ATP to ADP and P; and to 
determine Fmax of this reaction, which has not been directly 
possible in the bioluminescence assay since this assay is lim-
ited in the amount of ATP that can be added, we used a 
second, ATP-regenerating assay that couples the formation 
of ADP via the pyruvate kinase and lactic dehydrogenase 
reactions to an equimolar decrease in NADH that can be 
monitored by photometric analysis. Fig. 3 summarizes our 
experiments with different concentrations of MBP-NBF-2 
and increasing concentrations of ATP. In data not presented 
here, MBP alone as well as a fusion protein of MBP and the 
a-subunit of P-galactosidase expressed and purified under 
identical conditions as MBP-NBF-2 failed to cause any de-
crease in ^340 that would indicate nascent ADP. In contrast, 
the ATP hydrolysis rate of MBP-NBF-2 was found to be 
linear with the employed protein concentration, and a typical 
Michaelis-Menten plot is obtained when ATPase activity is 
plotted versus ATP concentration, resulting in a Km of 86 
|j,M and a rate constant of 0.37 min - 1 . From the experimental 
conditions the specific activity of the preparation was deter-
mined to be 5.7 XlO - 3 U/mg. Using the same assay, Km and 
first-order rate constant of (Na+,K+)ATPase (from dog kid-
ney, specific activity 1.2 U/mg, Sigma) were determined to be 
191 |xM and 12.71 min - 1 , respectively. 
Our previous studies indicated a surprisingly high affinity of 
NBF-2 for AMP [18] which has been shown to exercise a 
strong inhibitory effect on CFTR channels [10]. Since there 
is evidence that ATP consuming enzymatic activity of NBF-2 
mediates channel closing [13,14], we were interested in the 
influence of AMP on the catalytic activity of NBF-2. As illus-
trated in Fig. 3, the addition of AMP causes a dramatic in-
crease in the formation of ADP. There is also a Michaelis-
Menten plot obtained when the rate of ADP formation is 
plotted versus AMP concentration at a constant saturating 
concentration of ATP. This second plot was characterized 
by a Km of 47.1 \iM and a rate constant of 1.47 min
- 1 . In 
both cases enzymatic activity could readily be inhibited by 
AMP-PNP (Ki = 158 uM without and 135 uM in the presence 
of 30 |0,M AMP, respectively). AMP had no effect on the 
catalytic activity of (Na+,K+)ATPase (data not shown). 
Two possible hypotheses could be delineated from the ob-
served results. First, AMP could be an allosteric effector that 
enhances hydrolysis of ATP to ADP and P; or, second, AMP 
could be a second substrate of NBF-2 as it would be the case 
Table 2 
Turnover of AMP, ADP and Pi in dependence of increasing AMP start concentrations 
MBP-NBF 2 
(UM) 
2 
2 
2 
2 
AMP start cone. 
(MM) 
-
30 
60 
100 
AMP end cone. 
(uM) 
-
11.06 
28.89 
48.42 
AMP turnover 
(uM) 
-
18.94 
31.11 
51.58 
ADP released 
(MM) 
14.67 
57.88 
72.72 
99.43 
Pi released 
(uM) 
12.87 
8.73 
6.63 
1.53 
The ATP concentration of 1 mM was high enough to remain practically constant. All reactions were carried out for 48 min and monitored in the 
'coupled' PK/LDH-containing enzymatic assay in order to avoid inhibition of the reactions by nascent ADP and to determine the amount of 
released ADP directly. Aliquots taken at begin and after stopping the reactions by quick freezing were used to determine the amounts of consumed 
AMP and of released Pi as described in Section 2. All experiments were repeated at least once with similar results. 
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Fig. 5. Evidence for two distinct binding sites for ATP and AMP. The fluorescence enhancement (AF) at 545 nm of excited (408 nm) TNP-
ATP due to binding to NBF-2, normalized referring to the asymptotic maximum of the fitted curve (AFm), is illustrated. AMP was not able to 
displace TNP-ATP since it could not diminish its fluorescence enhancement even in a 150-fold excess. This fluorescence signal was indeed due 
to nucleotide binding since it was readily de-enhancable by unlabelled ATP, an experiment performed as control. From this competition experi-
ment a similar corrected K& value (26.9 ±1.6 uM SEM, three experiments) for ATP could be determined as previously described for NBF-2 
fused to glutathione-S-transferase (37 uM [18]). 
in the adenylate kinase reaction where two molecules of ADP 
result from the transfer of the y-phosphate of ATP to AMP. 
In order to further distinguish between these two possibilities 
a third assay was performed, in which the release of inorganic 
phosphate is measured continuously. Results presented in Fig. 
4 show that phosphate is released in the presence of ATP and 
MBP-NBF-2. The rate of phosphate release is a linear func-
tion of the amount of added NBF-2 fusion protein. No phos-
phate release was obtained in control experiments using MBP 
or the above mentioned fusion protein of MBP and the oc-
subunit of p-galactosidase instead of MBP-NBF-2 (data not 
shown). In contrast to (Na+,K+)ATPase the rate of phos-
phate release catalysed by the NBF-2 fusion protein decreased 
rapidly over time indicating inhibition by a reaction product. 
Since nascent Pj is immediately consumed by the purine ribo-
nucleoside phosphorylase reaction it must be the nascent ADP 
that causes the inhibition — a phenomenon that could not be 
observed in the coupled PK/LDH assay which regenerates 
ATP from ADP. Further confirmation of the inhibitory effect 
of ADP was obtained by pre-incubating the assay with in-
creasing concentrations of ADP resulting in a strong, concen-
tration-dependent decrease of the initial rate of phosphate 
release (Fig. 4). 
In the presence of AMP, phosphate release from ATP was 
significantly reduced (Fig. 4) which rules out the hypothesis 
that AMP could be an allosteric effector of the ATPase reac-
tion but favors the view that both the ATPase and an adeny-
late kinase reaction are catalysed by NBF-2 in competition 
and that the portion of ADP resulting from simple ATP hy-
drolysis rapidly decreases with increasing amounts of AMP 
present in the assay. In order to prove this hypothesis we 
determined the amounts of both consumed AMP and of the 
nascent products ADP and P; under conditions of increasing 
AMP concentrations at an ATP concentration high enough to 
saturate NBF-2 completely and to remain practically constant 
over the time of reaction. Results given in Table 2 prove that 
AMP is a substrate of NBF-2 and that per molecule of AMP 
two molecules of ADP are released. This adenylate kinase 
reaction (ATP+AMP «-» ADP) is in competition with an 
ATPase reaction that predominates only at low AMP concen-
trations, a fact that rules out as well the possibility that a 
contaminating protein, either another ATPase or a non-spe-
cific phosphatase, is responsible for the observed ATP hydrol-
ysis. 
Taking our previous results, that both ATP and AMP bind 
to NBF-2 [18], together with the observation that both nu-
cleotides are substrates in the adenylate kinase reaction of 
NBF-2 implies that there must exist two distinct binding sites 
for ATP and AMP as it has been established for adenylate 
kinases [27,28]. To verify this assumption we tried to compete 
bound TNP-ATP by unlabelled AMP which should be readily 
possible with regard to their affinities to NBF-2 [18], if both 
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Fig. 6. Inhibition of ATPase ( A ) and ADK (•) activity of the 
NBF-2 fusion protein by Ap5A. Enzymatic activity at 1 mM ATP 
was monitored by following the formation of ADP in the 'coupled' 
(PK/LDH) ATP-regenerating enzymatic assay. Controls with ADP 
instead of MBP-NBF-2 and ATP assured that Ap5A had no effect 
on the assay enzymes. All experiments were repeated at least once, 
and similar results were obtained. 
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Fig. 7. GTP hydrolytic activity of the NBF-2 fusion protein monitored by following the formation of GDP in the 'coupled' PK/LDH contain-
ing assay. ApsA could readily inhibit GTPase activity of NBF-2. This experiment was repeated once with similar results. 
molecules bind to the same site. As shown in Fig. 5, AMP 
failed to replace bound TNP-ATP, which clearly indicates 
two distinct binding sites. 
Adenylate kinases are readily inhibited by adenosine(5')-
pentaphospho(5')adenosine (ApsA) that mimics the two sub-
strates ATP and AMP since it needs a three- and a mono-
phosphate position for binding [29,30]. As shown in Fig. 6 
ADK activity of the recombinant NBF-2 is strongly inhibited 
by Ap5A. In addition, the mere ATPase activity seen in the 
absence of AMP is likewise inhibited by Ap5A (Fig. 6). In 
data not presented, ApsA had no capacity to inhibit the en-
zymatic activity of (Na+,K+)ATPase. 
We have previously shown for NBF-2 that ATP and GTP 
bind to the same site. In order to reveal any intrinsic GTPase 
activity of the purified recombinant NBF-2 we employed a 
coupled GTP regenerating enzyme system detecting nascent 
GDP. In contrast to MBP or the cc-subunit of p-galactosidase 
fused to MBP and expressed in E. coli, which did not show 
any enzymatic activity, the MBP-NBF-2 fusion protein dem-
onstrated a rate of hydrolysis linearly increasing with the 
amount of protein in the assay. Fig. 7 shows a Michaelis-
Menten plot obtained by plotting GTPase activity versus 
GTP concentration with a Km value of 40 uM and a first-
order rate constant of 0.29 min - 1 . Addition of AMP or GMP 
did not influence the observed enzymatic activity (data not 
shown). The GTPase activity of NBF-2 could be completely 
inhibited by Ap5A (Fig. 7). 
The fact that all three observed enzymatic activities are 
inhibited by ApsA while the control ATPase, the 
(Na+,K+)ATPase, is not, is an additional very strong argu-
ment that the ATPase and GTPase activities described here 
are properties of the same molecule exhibiting ADK activity 
and not contributions of different, not detected contaminants 
of the purified MBP-NBF-2 fraction. 
This is the first report to provide direct evidence in vitro 
that the second nucleotide-binding fold of CFTR can function 
as an active ATPase, GTPase and adenylate kinase, which 
represents a unique combination of enzymatic properties. Be-
side the ATP/GTP-binding site a distinct AMP-binding site 
exists. With increasing concentrations of AMP in the presence 
of ATP the ADK activity quickly surpasses the ATPase ac-
tivity. ADP inhibits the ATPase activity. It is tempting to 
speculate that the inhibitory effect of ADP on CFTR channel 
gating [11] is the consequence of interference with activating 
ATP hydrolysis. The strong inhibition of CFTR Cl~ currents 
in the presence of cytoplasmic AMP [10] could be the result of 
high ADP formation at NBF-2 that consecutively inhibits 
ATP hydrolysis. 
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